WVE - Wave jumps on trial data for Huntington's disease therapy
2024-06-25 08:13:12 ET
More on Takeda, Wave Life Sciences, etc.
- Takeda: Strong Growth Catalysts And Maturing Pipeline Continue To Limit Downside Risk
- Takeda Pharmaceutical Company Limited (TAK) Fiscal Year 2023 Earnings Call Transcript
- Wave Life Sciences Ltd. (WVE) Q1 2024 Earnings Call Transcript
- Takeda gets Japan nod for first post-transplant anti-CMV treatment
- Takeda gets EU approval for Fruzaqla for colorectal cancer